Human myelin basic protein peptide 69-89: immunochemical features and use in immunoassays of cerebrospinal fluid.
The characteristics and heterogeneity of the myelin basic protein (MBP)-like material appearing in cerebrospinal fluid (CSF) after acute central nervous system (CNS) myelin injury are unresolved. Antigenic material containing an epitope in the carboxyl-terminal portion of human MBP peptide 45-89 (from the intact molecule of 170 residues) is a prominent species of the MBP-like material present. In an effort to define further the MBP-like material in CSF and to enhance its detection, a modified double-antibody radioimmunoassay has been developed using a radioligand of human MBP synthetic peptide 69-89. This assay is more sensitive with results paralleling those of previously used MBP assays for CNS myelin damage. Results with this assay provide additional confirmation of the presence of an epitope of MBP in the decapeptide of MBP 80-89 but in a conformation simulating that of intact MBP in CSF after CNS myelin injury. Unexpected buffer effects were noted to influence the immunochemical behavior of some of the small peptides of MBP.
Whitaker
J N
JN
Neurology Service, Birmingham Veterans Administration Medical Center, Birmingham, AL 35294.
Herman
P K
PK
D001667:Binding, Competitive; D002021:Buffers; D000939:Epitopes; D006801:Humans; D004676:Myelin Basic Protein / Q000134:cerebrospinal fluid / Q000276:immunology*; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid; D009842:Oligopeptides / Q000138:chemical synthesis / Q000276:immunology; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology; D011863:Radioimmunoassay; D013329:Structure-Activity Relationship
D002021:Buffers; D000939:Epitopes; D004676:Myelin Basic Protein; D009842:Oligopeptides; D010455:Peptides